## BR: Broadridge Financial Solutions, - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -1.8% below STRENGTH zone (4.0-10.0%); PEG 1.87 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($219.42)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-13 | UBS | $250 | $280 | -11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-13 | UBS | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 20 ($0.00M) |
| Sells | 2 ($2.17M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.1% (+1.8%)
- Blackrock Inc.: 8.9% (-1.0%)
- State Street Corpora: 4.8% (-0.4%)
- Morgan Stanley: 3.9% (-11.0%)
- Alliancebernstein L.: 3.2% (+692.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.87 elevated, pricing in significant growth expectations. Forward P/E 22.2x stretched relative to 9% growth. Quality metrics strong (ROE 38%). Analyst sentiment negative (1 target cuts vs 0 raises). Insider selling cluster ($2.2M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $26.6B |
| Beta | 0.99 |
| 52W Range | $212.33 - $271.91 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.87 |
| Forward P/E | 22.2 |
| Current P/E | 24.1 |
| YoY Growth | 8.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -0.6% to -1.8% (-1.2% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.8pp (needs >4.0% for momentum thesis). Below SMA200 (0.95x), long-term trend not supportive. MACD histogram positive (0.70), confirming momentum. RSI neutral at 49.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.76% (CS: 42) | Neutral |
| RSI_14 | 49.1 | Neutral |
| MACD Histogram | 0.70 | Bullish |
| vs SMA20 | 1.003x | Above |
| vs SMA50 | 0.995x | Below |
| vs SMA200 | 0.953x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $227.54
- **Stop Loss:** $219.42 (3.6% risk)
- **Target:** $235.66 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 147
- **Position Value:** $33,448.38
- **Portfolio %:** 33.45%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-01-29 (Est: $1.36)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.25 | $1.51 | +21.2% |
| 2025Q2 | $3.50 | $3.55 | +1.5% |
| 2025Q1 | $2.41 | $2.44 | +1.2% |
| 2024Q4 | $1.49 | $1.56 | +4.9% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*